Resonant Capital Advisors LLC Has $394,000 Stock Position in HCA Healthcare, Inc. $HCA

28 Oct 2025, 11:10 by Teresa Graham · The Cerbat Gem

Resonant Capital Advisors LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 22.8% in the second quarter, Holdings Channel reports. The institutional investor owned 1,028 shares of the company’s stock after acquiring an additional 191 shares during the period. Resonant Capital Advisors LLC’s holdings in HCA Healthcare were worth $394,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new position in HCA Healthcare during the first quarter worth about $26,000. Saudi Central Bank purchased a new position in HCA Healthcare during the first quarter worth about $26,000. WPG Advisers LLC purchased a new position in HCA Healthcare during the first quarter worth about $27,000. Ameriflex Group Inc. purchased a new position in HCA Healthcare during the second quarter worth about $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare during the second quarter worth about $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages have commented on HCA. Royal Bank Of Canada lifted their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday. Bank of America lifted their price objective on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Monday. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, The Goldman Sachs Group raised their price objective on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $471.42.

Read Our Latest Research Report on HCA Healthcare

HCA Healthcare Trading Up 4.8%

HCA Healthcare stock opened at $468.68 on Tuesday. The firm’s 50 day simple moving average is $416.33 and its 200 day simple moving average is $383.23. The firm has a market capitalization of $109.67 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 1.41 and a beta of 1.40. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $469.18.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

About HCA Healthcare

(Free Report)